Nasdaq: AVXL

Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Corp. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker AVXL. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
AVXL
Exchange
Nasdaq
SEC CIK
1314052
Official filings
SEC EDGAR

Research AVXL

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Anavex Life Sciences Corp.'s stock ticker?

Anavex Life Sciences Corp. trades under the ticker symbol AVXL on Nasdaq. Its SEC Central Index Key (CIK) is 1314052.

Where can I read Anavex Life Sciences Corp.'s SEC filings?

The AVXL SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Anavex Life Sciences Corp. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze AVXL's financial statements?

The AVXL Financials page shows Anavex Life Sciences Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does AVXL compare with its peers and the market?

The AVXL Peer Comparison page lines Anavex Life Sciences Corp. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.